Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
GARDEN CITY, N.Y., Jan. 18, 2024 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ:XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. (“Beyond Cancer”)), today announced that it will report financial results for its third fiscal quarter ended December 31, 2023 on Monday, February 12, 2024. The Company’s management team is scheduled to host a conference call and webcast at 4:30 pm Eastern Time the same day.
Related news for (XAIR)
- Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
- 24/7 Market News Snapshot 08 September, 2025 – Beyond Air, Inc. Common Stock (NASDAQ:XAIR)
- SaaS Pivots, AI Bets, and Green Tech Grabs, with Eyes on Innovation
- MoBot alert highlights: NASDAQ: OCTO, NASDAQ: AIRE, NASDAQ: NAKA, NASDAQ: XAIR, NASDAQ: SKYQ (09/08/25 09:00 AM)
- MoBot’s Stock Market Highlights – 09/08/25 08:00 AM